SCHEMBL30142906

SCHEMBL30142906

CC(=O)Nc1ccccc1C(=O)Nc1ncc(C(C)C)s1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 7/20 0.64
CCNE1 P24864 6/20 0.64
CDK5 Q00535 6/20 0.64
ALDH1A1 P00352 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
CCNT1 O60563 1/20 0.54
CDK1 P06493 1/20 0.54
CDK4 P11802 1/20 0.54
CCNB1 P14635 1/20 0.54
CCNA2 P20248 1/20 0.54
CCND1 P24385 1/20 0.54
CDK7 P50613 1/20 0.54
CDK9 P50750 1/20 0.54
CCNH P51946 1/20 0.54
MNAT1 P51948 1/20 0.54
CDK5R1 Q15078 1/20 0.54
FDPS P14324 1/20 0.45
KDM4E B2RXH2 1/20 0.44
POLB P06746 2/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24072507 1.00 CDK2 (0.64) CDK2CCNE1CDK5ALDH1A1SMN1; SMN2
SCHEMBL5835764 0.89 CDK2 (0.66) CDK2CCNE1CDK5ALDH1A1SMN1; SMN2
SCHEMBL5835388 0.85 CDK2 (0.67) CDK2CCNE1CDK5ALDH1A1SMN1; SMN2
SCHEMBL6284013 0.83 CDK2 (0.76) CDK2CCNE1CDK5ALDH1A1SMN1; SMN2
SCHEMBL30142884 0.83 NPC1 (0.59) ALDH1A1SMN1; SMN2KDM4EPOLBMEN1
SCHEMBL5836180 0.83 CDK2 (0.69) CDK2CCNE1CDK5ALDH1A1SMN1; SMN2
SCHEMBL6177659 0.83 CDK2 (0.73) CDK2CCNE1CDK5ALDH1A1SMN1; SMN2
SCHEMBL24074020 0.83 NPC1 (0.59) ALDH1A1SMN1; SMN2KDM4EPOLBMEN1
SCHEMBL30142626 0.82 KDR (0.65) CDK2CCNE1CDK5KDM4EPOLB
SCHEMBL24074022 0.82 KDR (0.65) CDK2CCNE1CDK5KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
CN-116472292-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2023-07-21 CN disclosed
EP-4157888-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS Cullgen (Shanghai), Inc. (CN) 2023-04-05 EP disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 CDK2 500/4885CCNE1 696/4885CDK5 1532/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 CDK2 500/4885CCNE1 696/4885CDK5 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.